Opendata, web and dolomites

PoCMICRUX

An affordable Multi-analyte Point-of-Care system for Chronic Disease Self-Control and Management

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PoCMICRUX project word cloud

Explore the words cloud of the PoCMICRUX project. It provides you a very rough idea of what is the project "PoCMICRUX" about.

fast    intend    profit    marketed    micrux    healthcare    unhealthy    prevention    countries    57    turnover    forefront    total    150    innovative    components    uric    care    capillary    lab    people    analyte    launching    cholesterol    training    ratio    expectancies    create    made    chip    too    overcome    sensor    life    simply    first    electrochemical    point    foundation    technologies    combination    validated    barrier    remarkable    microfluidic    tools    health    calibration    afforded    disease    miniaturized    poct    poc    diabetes    2023    profitability    blood    monitoring    expensive    models    glucose    acid    patients    chronic    jobs    market    accumulated    self    clinical    fluid    lifestyle    pocmicrux    drop    handheld    longer    dramatically    creatinine    26    home    handled    electronical    expenditure    company    cumulative    diseases    budget    device    diagnostic    spanish    accurately    cardiovascular    700    lt    billion    succeeded    multiple    commercialization    foresee    prevalence    simultaneously    2008    instrumentation    kidney    million    biomarkers    min    totally    70    action   

Project "PoCMICRUX" data sheet

The following table provides information about the project.

Coordinator
MICRUX FLUIDIC SL 

Organization address
address: CALLE JULIAN CLAVERIA - EDIFICIO SCTS SEVERO OCHOA S/N
city: OVIEDO
postcode: 33006
website: www.micruxfluidic.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.micruxfluidic.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICRUX FLUIDIC SL ES (OVIEDO) coordinator 50˙000.00

Map

 Project objective

Longer life expectancies and unhealthy lifestyle has dramatically increase the prevalence multiple chronic conditions. There are over 50 million of people with such cumulative chronic conditions in Europe and, together, they total more than €700 billion healthcare expenditure which account for over 70% of the EU health budget. Recent Point-of-Care Testing (PoCT) technologies provide remarkable tools for home self-testing and management but the currently PoC on the market are still so complex and too expensive to be afforded by average patients. With PoCMicruX we intend to overcome this barrier and finally provide patients the first low-cost multi-analyte handheld Point-of-Care device for multiple chronic disease self-testing and management. PoCMicruX is a combination of microfluidic and electrochemical sensor technologies. Based on an innovative design totally made of electronical components and where fluid can simply be handled by capillary action, we will offer the only cost-effective (€150), simple (one drop of blood, no training or calibration required), fast (<2 min), and handheld PoC device allowing patients to accurately self-test simultaneously four clinical validated biomarkers (glucose, cholesterol, creatinine and uric acid) for the clinical diagnostic (monitoring and prevention) of high prevalence diseases such as diabetes, cholesterol, cardiovascular and kidney diseases. MicruX Technologies is a highly innovative Spanish company that, from its foundation in 2008, has been at the forefront of developing miniaturized lab-on-chip technology and miniaturized monitoring instrumentation, being already involved in several EU projects. We have already succeeded in launching more than 30 models of products currently marketed in 40 countries. We expect from PoCMicruX commercialization to provide an accumulated turnover of €26.7 million by 2023, with 8.5 million profit (profitability ratio of 57%). We foresee to create 50 new jobs by 2023.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "POCMICRUX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "POCMICRUX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Presque (2019)

Smart Nursing Bra

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More